Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

NSE : KIMSBSE : 543308ISIN CODE : INE967H01025Industry : Hospital & Healthcare ServicesHouse : Private

BSE569.9520.1 (+3.66 %)

PREV CLOSE ( ) 549.85

OPEN PRICE ( ) 554.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 36022

TODAY'S LOW / HIGH ( )533.25 575.00

52 WK LOW / HIGH ( )350.02 674

NSE570.5520.85 (+3.79 %)

PREV CLOSE( ) 549.70

OPEN PRICE ( ) 553.00

BID PRICE (QTY) 570.55 (70)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 784658

TODAY'S LOW / HIGH( ) 533.25 579.00

52 WK LOW / HIGH ( )350 674.3

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

4596.37

4849.07

4568.53

2790.15

1405.26

Adjustment

1861.68

1136.96

685.37

1005.55

1145.31

Changes In working Capital

154.31

-692.81

-744.68

141.48

1.15

Cash Flow after changes in Working Capital

6612.36

5293.22

4509.22

3937.18

2551.72

Cash Flow from Operating Activities

5210.85

4320.87

3240.25

3559.74

2015.00

Cash Flow from Investing Activities

-7525.60

-5468.94

-4115.20

-3541.78

-1247.11

Cash Flow from Financing Activities

2167.55

196.42

610.00

98.19

-443.38

Net Cash Inflow / Outflow

-147.20

-951.65

-264.95

116.15

324.51

Opening Cash & Cash Equivalents

616.11

256.34

521.29

405.14

80.63

Cash & Cash Equivalent on Amalgamation / Take over / Merger

1311.42

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

468.91

616.11

256.34

521.29

405.14